US equities |
MU $983.23 ▲+5.86% META $612.49 ▼-1.24% NVDA $215.38 ▼-1.17% GOOGL $324.89 ▲+1.34% MSFT $531.01 ▼-0.06% TSLA $404.22 ▼-0.80% SPCX $145.23 ▼-2.25% SNDK $1,404.77 ▲+7.66%
FinancialContent

Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

12.74 +0.79 (+6.65%)
Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
What's Going On With Amarin Stock? ↗
Amarin Corporation (NASDAQ: AMRN) shares are trading higher Wednesday after the company released a business update and announced a conditional s 
Via Benzinga
News headline image
Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Why Amarin Stock Is Sinking Today ↗
The drugmaker announced a major corporate reorganization and a new CEO. 
Via The Motley Fool
News headline image
Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript ↗
AMRN earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
Amarin Reports Third Quarter 2023 Financial Results
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin Appoints Jonathan Provoost Executive Vice President, Chief Legal & Compliance Officer
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Latest Research Evaluating VASCEPA®/VAZKEPA® (icosapent ethyl) and Subgroups from the REDUCE-IT Landmark Outcomes Trial to be Presented at the American Heart Association (AHA) Scientific Sessions 2023
-- Additional Mechanistic Data on Eicosapentaenoic Acid (EPA) and Real-World Characteristics of Patients with Diabetes on IPE Also Featured at the Meeting -- 
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Alphabet To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
News headline image
Amarin to Report Third Quarter 2023 Financial Results and Host Conference Call on November 1, 2023
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin to Present at the 2023 Cantor Global Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Trade Desk, Plug Power, TaskUs And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin Reports Second Quarter 2023 Financial Results
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
Collaboration Broadens Reach of VAZKEPA to Additional Ten Countries Leveraging Lotus’ Established Commercial and Marketing Expertise in the Region 
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Amarin Board of Directors Announces Executive Compensation Program for New President and CEO Patrick Holt
From Amarin Corporation plc
Via GlobeNewswire
News headline image
Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected ↗
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also... 
Via Benzinga
News headline image
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,... 
Via Benzinga
News headline image
Why Are Amarin Shares Plunging Today? ↗
Amarin Corporation plc (NASDAQ: AMRN) shares are down after the company on Tuesday announced that it was restructuring in an effort to reduce operating costs by approximately  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >